We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+13.04%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$12.9B
AUM Growth
+$1.9B
Cap. Flow
+$442M
Cap. Flow %
3.42%
Top 10 Hldgs %
34.89%
Holding
1,323
New
145
Increased
499
Reduced
420
Closed
63

Top Buys

Rank Stock Value
1
COLD icon
Americold
COLD
+$166M
2
OHI icon
Omega Healthcare
OHI
+$102M
3
SUI icon
Sun Communities
SUI
+$98.2M
4
AIRC
Apartment Income REIT Corp.
AIRC
+$97.3M
5
DOC icon
Healthpeak Properties
DOC
+$93.5M

Top Sells

Rank Stock Value
1
EQIX icon
Equinix
EQIX
+$261M
2
PLD icon
Prologis
PLD
+$67.9M
3
KRC icon
Kilroy Realty
KRC
+$67.2M
4
WELL icon
Welltower
WELL
+$62.1M
5
STOR
STORE Capital Corporation
STOR
+$56.9M

Sector Composition

Rank Sector Weight
1 Real Estate 60.68%
2 Technology 7.51%
3 Communication Services 3.68%
4 Healthcare 3.56%
5 Consumer Discretionary 3.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RETA
1026
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$7K ﹤0.01%
54
-106
-66% -$13.9K
ZNH
1027
DELISTED
China Southern Airlines Company Limited
ZNH
$7K ﹤0.01%
250
-250
-50% -$7.4K
GWPH
1028
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$7K ﹤0.01%
57
-113
-66% -$12.7K
AGIO icon
1029
Agios Pharmaceuticals
AGIO
$2.08B
$6K ﹤0.01%
130
-256
-66% -$10.1K
ALKS icon
1030
Alkermes
ALKS
$8.11B
$6K ﹤0.01%
299
-590
-66% -$10.8K
ALXO icon
1031
ALX Oncology
ALXO
$262M
$6K ﹤0.01%
+70
New +$4.21K
ARVN icon
1032
Arvinas
ARVN
$530M
$6K ﹤0.01%
76
-144
-65% -$4.97K
AXSM icon
1033
Axsome Therapeutics
AXSM
$11.7B
$6K ﹤0.01%
70
-139
-67% -$10.4K
KYNB
1034
Kyntra Bio
KYNB
$27.4M
$6K ﹤0.01%
7
-13
-65% -$13.7K
INSM icon
1035
Insmed
INSM
$22.4B
$6K ﹤0.01%
192
-384
-67% -$14K
NKTR icon
1036
Nektar Therapeutics
NKTR
$2.39B
$6K ﹤0.01%
22
-44
-67% -$11.4K
NTLA icon
1037
Intellia Therapeutics
NTLA
$1.51B
$6K ﹤0.01%
111
-177
-61% -$6.43K
RCKT icon
1038
Rocket Pharmaceuticals
RCKT
$343M
$6K ﹤0.01%
104
-210
-67% -$7.66K
UA icon
1039
Under Armour Class C
UA
$2.95B
$6K ﹤0.01%
376
– –
VIR icon
1040
Vir Biotechnology
VIR
$1.46B
$6K ﹤0.01%
+240
New +$7.8K
DCPH
1041
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$6K ﹤0.01%
107
-211
-66% -$12.5K
NSTG
1042
DELISTED
NanoString Technologies, Inc.
NSTG
$6K ﹤0.01%
83
-119
-59% -$5.97K
BLUE
1043
DELISTED
bluebird bio
BLUE
$5K ﹤0.01%
10
-18
-64% -$11.4K
PCRX icon
1044
Pacira BioSciences
PCRX
$1.04B
$5K ﹤0.01%
82
-154
-65% -$9.02K
RVMD icon
1045
Revolution Medicines
RVMD
$38.5B
$5K ﹤0.01%
+125
New +$4.94K
SNAP icon
1046
PUT
Snap
SNAP
$7.96B
$5K ﹤0.01%
1,085
– –
VCYT icon
1047
Veracyte
VCYT
$4.45B
$5K ﹤0.01%
109
-167
-61% -$7.74K
XNCR icon
1048
Xencor
XNCR
$1.45B
$5K ﹤0.01%
108
-212
-66% -$8.77K
KLRS
1049
Kalaris Therapeutics
KLRS
$80.9M
$5K ﹤0.01%
+5
New +$3.85K
ITCI
1050
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$5K ﹤0.01%
151
-213
-59% -$5.6K
40 41
42
43 44

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Daiwa Securities Group's Q4 2020 Portfolio in Review

As of Q4 2020, Daiwa Securities Group held 1,323 positions worth $12.9B, up 17% from $11B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Daiwa Securities Group deployed $442M of net new capital in Q4 2020, opening 145 new positions and adding to 499 existing holdings. Its largest new stake was Apartment Income REIT Corp.: 2,533,191 shares worth $97.3M.

By sector, the portfolio is most concentrated in Real Estate at 61% of assets, down from 62% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Equinix, an estimated $261M trimmed.

  • Daiwa Securities Group's largest Q4 2020 buy was Apartment Income REIT Corp.: 2,533,191 shares worth $97.3M.
  • Daiwa Securities Group added most to Americold in Q4 2020, an estimated $166M increase.
  • Daiwa Securities Group's biggest Q4 2020 reduction was Equinix, cutting an estimated $261M.
  • Daiwa Securities Group fully exited NextEra Energy, Inc. 6.219% Corporate Units in Q4 2020, selling an estimated $16.6M.
  • Daiwa Securities Group's ten largest holdings make up 35% of its $12.9B portfolio in Q4 2020.
  • Daiwa Securities Group opened 145 new positions and closed 63 in Q4 2020.
  • Daiwa Securities Group's portfolio value rose 17% quarter-over-quarter to $12.9B.

Based on Daiwa Securities Group's 13F filing for Q4 2020, filed 4 Feb 2021.